Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (161-170 of 237) with videos related to

Pageof 24
Sort By:
AJNR. American Journal of Neuroradiology|April 4, 2020
Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor ConsortiumS Vajapeyam, D Brown, C Billups, et al.
Pediatric Blood & Cancer|August 8, 2022
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastomaSameer Farouk Sait, Mauricio Rendon Bernot, Elizabeth Klein, et al.
Pediatric Blood & Cancer|January 20, 2018
BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanomaJulia C Chisholm, Jozef Suvada, Ira J Dunkel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2024
Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion DosimetryNeeta Pandit-Taskar, Pat B Zanzonico, Milan Grkovski, et al.
Pediatric Blood & Cancer|October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trialJason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Pediatric Blood & Cancer|October 11, 2023
A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1)Murali Chintagumpala, Jin Piao, Dan Gombos, et al.
Journal of Neuro-Oncology|October 12, 2017
Long-term outcomes of adult medulloblastoma patients treated with radiotherapyBrian De, Kathryn Beal, Kevin C De Braganca, et al.
Pediatric Blood & Cancer|May 13, 2009
Familial retinoblastoma in developing countriesGuillermo L Chantada, Ira J Dunkel, Ibrahim Qaddoumi, et al.
Pediatric Blood & Cancer|September 15, 2006
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignanciesStephen W Gilheeney, David C Lyden, Shirley Sgouros, et al.
Pageof 24

Showing results (161-170 of 237) with videos related to

Sort By:
Pageof 24
AJNR. American Journal of Neuroradiology|April 4, 2020
Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor ConsortiumS Vajapeyam, D Brown, C Billups, et al.
Pediatric Blood & Cancer|August 8, 2022
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastomaSameer Farouk Sait, Mauricio Rendon Bernot, Elizabeth Klein, et al.
Pediatric Blood & Cancer|January 20, 2018
BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanomaJulia C Chisholm, Jozef Suvada, Ira J Dunkel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 14, 2024
Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion DosimetryNeeta Pandit-Taskar, Pat B Zanzonico, Milan Grkovski, et al.
Pediatric Blood & Cancer|October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trialJason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
Pediatric Blood & Cancer|July 28, 2017
Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosisSara Zarnegar, Benjamin H Durham, Pallavi Khattar, et al.
Pediatric Blood & Cancer|October 11, 2023
A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1)Murali Chintagumpala, Jin Piao, Dan Gombos, et al.
Journal of Neuro-Oncology|October 12, 2017
Long-term outcomes of adult medulloblastoma patients treated with radiotherapyBrian De, Kathryn Beal, Kevin C De Braganca, et al.
Pediatric Blood & Cancer|May 13, 2009
Familial retinoblastoma in developing countriesGuillermo L Chantada, Ira J Dunkel, Ibrahim Qaddoumi, et al.
Pediatric Blood & Cancer|September 15, 2006
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignanciesStephen W Gilheeney, David C Lyden, Shirley Sgouros, et al.
Pageof 24